DEPDC1B and posterior cortical atrophy: To further investigate whether DEPDC1B was involved in clinical PCa progression at the protein level, we analyzed a TMA cohort (Cohort 1) consisting of 192 samples that included normal, primary tumors, and LN metastases and a large‐scale sample cohort (Cohort 2) containing 103 PCa specimens.